Archives by: Dr.med. Napoleon DeLeon

Dr.med. Napoleon DeLeon

44 Posts 0 comments

About the author

Dr.med. Napoleon DeLeon holds a degree in medicine from the United Arab Emirates College, Al Ain, UAE. With over 15 years of experience, he is an expert in evaluating and curating healthcare web content based on clinical evidence.

Dr.med. Napoleon DeLeon Posts

Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team

Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team
RENOWNED ADVOCATE AND SCIENTIST TAKES ON MEDICAL ADVISOR ROLE FOR EVOLVE FORMULAS DENVER, June 7, 2018 /PRNewswire/ — Dr. Michele Ross, neuroscientist, author and cannabinoid medicine leader, has joined the advisory ...
Read more 0

NanoSphere Partners with Gofire to Debut DoseCode-Enabled Products in Colorado Market

NanoSphere Partners with Gofire to Debut DoseCode-Enabled Products in Colorado Market
—Scannable Technology Grants Patients Access to Descriptions, Reviews and Dosing Information for Evolve Formulas Products— DENVER (December 6, 2018) – NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF), ...
Read more 0

NanoSphere Health Sciences To Report Revenue and Sees Significant Sales Growth in Second Quarter

NanoSphere Health Sciences To Report Revenue and Sees Significant Sales Growth in Second Quarter
BIOTECH LEADER INCREASES CANNABIS BRAND SALES IN COLORADO BY 30 PERCENT AHEAD OF CALIFORNIA LAUNCH DENVER (July 4, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the biotech ...
Read more 0

NanoSphere Health Sciences Partners with Delta 9 for Canadian Expansion

NanoSphere Health Sciences Partners with Delta 9 for Canadian Expansion
BIOTECH LEADER’S CANNABIS DIVISION, EVOLVE FORMULAS, PREPARES TO LAUNCH IN CANADIAN MARKET DENVER (July 31, 2018)- NanoSphere Health Sciences, INC (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented ...
Read more 0

NanoSphere Health Sciences Secures Patent For Groundbreaking Nanoparticle Delivery of Cannabis

NanoSphere Health Sciences Secures Patent For Groundbreaking Nanoparticle Delivery of Cannabis
BIOTECH LEADER NOW OWNS FIRST AND ONLY CANNABIS NANOPARTICLE DELIVERY SYSTEM IN NORTH AMERICA Denver (July 24, 2018) — NanoSphere Health Sciences LLC (CSE: NSHS) (OTC: NSHSF) has been awarded ...
Read more 0

News

News
NanoSphere Health Sciences Announces Retirement of CEO Robert E. Sutton; Dr. Mark Percival Named As Successor NANOSPHERE BOARD UNANIMOUSLY SELECTS DR. PERCIVAL AS NEW CEO Vancouver, June 10, ...
Read more 0

Investor Relations

Investor Relations
Investor Information Use the button below to gain access to our Investor FAQ Sheet, Investor Presentation and our Subscription Agreement document. Latest News NanoSphere Health Sciences Announces Retirement ...
Read more 0

About NanoSphere Health

About NanoSphere Health
Our Company NanoSphere Health Sciences Inc. is a leading nano-biotechnology company with advanced: Patent protected delivery systems Specialized manufacturing technology and expertise Custom product formulations Our Mission To ...
Read more 0

Cannabis

Cannabis
NanoSphere’s award-winning brand Evolve Formulas is revolutionizing how cannabis delivers its benefits. This innovation is the extension of Evolve’s NanoSphere Delivery System™ dramatically improving absorption, distribution and bioavailability. Launched ...
Read more 0

Licensing

Licensing
NanoSphere Health works closely with clients to successfully establish our NanoSphere Delivery System™ formulation solutions. Our NanoSphere Delivery System™ is highly scalable, rapid, cost-efficient and occupies a small ...
Read more 0